三重Toll样受体激动剂佐剂灭活新城疫病毒疫苗促进鸡有效Th1/Th2免疫应答并提供保护效力
研究探讨三重Toll样受体(TLR)激动剂组合(LPS/TLR4、R-848/TLR7、CpG-ODN/TLR21)作为灭活新城疫病毒(NDV)疫苗佐剂在鸡中的应用。体外刺激鸡外周血单核细胞及脾转录组分析显示促炎、抗病毒及混合Th1/Th2应答相关基因上调;免疫研究中低剂量三重TLR激动剂组合无毒性,显著增强体液和细胞免疫应答,抗体滴度更高、T细胞活化增加,并对强毒NDV攻击提供完全保护。
要点
- 三重TLR激动剂组合刺激鸡PBMCs后IL-1β、IFN-γ、IL-4、IFN-β、iNOS和MHC-II转录本显著上调。
- 脾转录组分析显示三重TLR激动剂信号通路中19个免疫功能相关差异表达基因显著上调。
- 低剂量三重TLR激动剂佐剂无毒性,增强体液和细胞免疫,对强毒NDV攻击提供完全保护。
核心结论
- 三重TLR激动剂组合可提高疫苗效力,并为疫苗配方提供一种成本效益方法。
研究设计与样本
- 研究评估三重TLR激动剂组合(LPS/TLR4、R-848/TLR7、CpG-ODN/TLR21)作为灭活NDV疫苗佐剂在鸡中的应用。
- 体外用三重激动剂组合刺激鸡外周血单核细胞,用定量PCR分析免疫相关基因表达。
- 对注射三重TLR激动剂的鸡脾样本进行转录组分析。
- 免疫研究中鸡单独接种灭活NDV疫苗或联合不同TLR激动剂混合物(单、双或三重),评估体液和细胞免疫应答及攻毒保护。
主要发现
- 免疫应答研究显示IL-1β、IFN-γ、IL-4、IFN-β、iNOS和MHC-II转录本显著上调,表明三重TLR激动剂组合诱导促炎、抗病毒和混合Th1/Th2应答。
- 转录组分析显示三重TLR激动剂信号通路中19个免疫功能相关差异表达基因显著上调,包括促炎、抗炎和抗病毒应答。
- 免疫研究显示低剂量三重TLR激动剂组合无毒性,显著增强体液和细胞介导免疫应答,导致抗体滴度更高、T细胞活化增加,并对强毒NDV攻击提供完全保护。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Combinations of Toll-like receptor (TLR) agonists are being explored to alleviate systemic toxicity and achieve long-lasting desirable immune responses. In this study, we investigated the use of a triple-TLR agonists' combination (LPS, TLR4; R-848, TLR7 and CpG-ODN, TLR21) as an adjuvant with the inactivated Newcastle disease virus (NDV) vaccine in chickens. We assessed the immune response kinetics by stimulating chicken peripheral blood mononuclear cells (PBMCs) with the triple agonist combination and analyzing immune-related gene expression using quantitative PCR. Additionally, transcriptomic analysis was performed in spleen samples from birds injected with the triple TLR agonists. In the immunization study, birds were vaccinated with an inactivated NDV vaccine alone or in combination with different TLR agonist mixtures (single, dual, or triple), followed by assessment of both humoral and cellular immune responses and protection against challenge. Results from immune response study showed significant upregulation of IL-1β, IFN-γ, IL-4, IFN-β, iNOS and MHC-II transcripts, indicating the pro-inflammatory, anti-viral and mixed Th1/Th2 responses in triple TLR agonists' combination. Transcriptomic analysis revealed significant upregulation of 19 differentially expressed genes (DEGs) related to immune function in triple-TLR agonists signaling pathway such as pro-inflammatory, anti-inflammatory and anti-viral response. Furthermore, the immunization study demonstrated that the triple-TLR agonist combination, at a low dose exhibited no toxicity and significantly enhanced both humoral and cell-mediated immune responses, leading to higher antibody titres, increased T cell activation, and complete protection against a virulent NDV challenge. These findings suggest that the triple-TLR agonists' combination could improve vaccine efficacy and provide a cost-effective approach for vaccine formulations.
引用
- Kaliappan A, Ramakrishnan S, Panwar K, et al. Triple-TLR agonists' adjuvanted inactivated Newcastle disease virus vaccine promotes effective Th1/Th2 immune responses and affords protective efficacy in chickens. Vaccine. 2025. PMID: 41082811. doi:10.1016/j.vaccine.2025.127846
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。